Following pleasantly surprising Q3 results, Tilray shares outperformed those of industry peers on Wednesday. Despite the firm’s positive trading day, the MORE Act’s questionable prospects may be casting a shadow over the cannabis industry as a whole.
Over the past few weeks, many companies imposed sanctions on Russia in an effort to halt Russia’s military activities in Ukraine. Despite the losses incurred by these companies, on Tuesday, other major names in the field joined the wave of sanctions. How could this affect their stocks?